Long‐term sevelamer treatment lowers serum fibroblast growth factor 23 accompanied with increasing serum K lotho levels in chronic haemodialysis patients

HH Lin, HH Liou, MS Wu, CY Lin, CC Huang - Nephrology, 2014 - Wiley Online Library
Aims Fibroblast growth factor 23 (FGF 23) and K lotho are associated with vascular
calcification and cardiovascular disease in dialysis patients. Sevelamer has been shown to …
被引用次数：47 相关文章

Long-term sevelamer treatment lowers serum fibroblast growth factor 23 accompanied with increasing serum Klotho levels in chronic haemodialysis patients.

HH Lin, HH Liou, MS Wu, CY Lin, CC Huang - Nephrology, 2014 - search.ebscohost.com
Aims Fibroblast growth factor 23 (FGF23) and Klotho are associated with vascular
calcification and cardiovascular disease in dialysis patients. Sevelamer has been shown to …

Long‐term sevelamer treatment lowers serum fibroblast growth factor 23 accompanied with increasing serum K lotho levels in chronic haemodialysis patients

HH Lin, HH Liou, MS Wu, CY Lin, CC Huang - Nephrology, 2014 - infona.pl
Aims Fibroblast growth factor 23 (FGF 23) and K lotho are associated with vascular
calcification and cardiovascular disease in dialysis patients. Sevelamer has been shown to …

Long-term sevelamer treatment lowers serum fibroblast growth factor 23 accompanied with increasing serum Klotho levels in chronic haemodialysis patients

HH Lin, HH Liou, MS Wu, CY Lin, CC Huang - 2014 - pubmed.ncbi.nlm.nih.gov
Aims Fibroblast growth factor 23 (FGF23) and Klotho are associated with vascular
calcification and cardiovascular disease in dialysis patients. Sevelamer has been shown to …

Long-term sevelamer treatment lowers serum fibroblast growth factor 23 accompanied with increasing serum Klotho levels in chronic haemodialysis patients.

HH Lin, HH Liou, MS Wu, CY Lin… - Nephrology (Carlton, Vic …, 2014 - europepmc.org
Aims Fibroblast growth factor 23 (FGF23) and Klotho are associated with vascular
calcification and cardiovascular disease in dialysis patients. Sevelamer has been shown to …

Long-term sevelamer treatment lowers serum fibroblast growth factor 23 accompanied with increasing serum Klotho levels in chronic haemodialysis patients

HH Lin, HH Liou, MS Wu, CY Lin, CC Huang - Nephrology, 2014 - pure.lib.cgu.edu.tw
Aims: Fibroblast growth factor 23 (FGF23) and Klotho are associated with vascular
calcification and cardiovascular disease in dialysis patients. Sevelamer has been shown to …

Long-term sevelamer treatment lowers serum fibroblast growth factor 23 accompanied with increasing serum Klotho levels in chronic haemodialysis patients

HH Lin, HH Liou, MS Wu, CY Lin, CC Huang - Nephrology, 2014 - pure.lib.cgu.edu.tw
Aims: Fibroblast growth factor 23 (FGF23) and Klotho are associated with vascular
calcification and cardiovascular disease in dialysis patients. Sevelamer has been shown to …